CymaBay Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
6
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2022-06-30
|
-0.30
|
-0.31
|
-0.01
|
-3.33%
|
|
2022-03-31
|
-0.31
|
-0.32
|
-0.01
|
-3.23%
|
|
2021-12-31
|
-0.26
|
-0.34
|
-0.08
|
-30.77%
|
|
2021-09-30
|
-0.26
|
-0.33
|
-0.07
|
-26.92%
|
|
2021-06-30
|
-0.27
|
-0.34
|
-0.07
|
-25.93%
|
|
2021-03-31
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2020-12-31
|
-0.20
|
-0.23
|
-0.03
|
-15.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.91
|
|
2021-12-31
|
-1.26
|
|
2020-12-31
|
-0.75
|
|
2019-12-31
|
-1.45
|
|
2018-12-31
|
-1.25
|
|
2017-12-31
|
-0.83
|
|
2016-12-31
|
-1.14
|
|
2015-12-31
|
-0.77
|
|
2014-12-31
|
-2.89
|
|
2013-12-31
|
-1.38
|